Isavuconazole + Voriconazole
Phase 3Completed 0 views this week 0 watching⚡ Active
Interest: 40/100
40
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Aspergillosis
Conditions
Aspergillosis, Invasive Fungal Infection
Trial Timeline
Mar 7, 2007 → Mar 28, 2013
NCT ID
NCT00412893About Isavuconazole + Voriconazole
Isavuconazole + Voriconazole is a phase 3 stage product being developed by Astellas Pharma for Aspergillosis. The current trial status is completed. This product is registered under clinical trial identifier NCT00412893. Target conditions include Aspergillosis, Invasive Fungal Infection.
What happened to similar drugs?
8 of 15 similar drugs in Aspergillosis were approved
Approved (8) Terminated (6) Active (5)
Hype Score Breakdown
Clinical
17
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00412893 | Phase 3 | Completed |
Competing Products
20 competing products in Aspergillosis